We developed a bioanalytical method of paclitaxel-cholesterol conjugate (CHO-PTX).
Murine plasma and tumors distribution of CHO-PTX was measured by LC–APCI-MS/MS.
We observed the high distribution of CHO-PTX in tumors relative to plasma levels.
Cholesteryl-drug conjugate is a promising approach for tumor targeting therapy.